Showing 6981-6990 of 7564 results for "".
- Topix Pharmaceuticals Partners with New Mountain Capitalhttps://practicaldermatology.com/news/new-mountain-capital-partners-with-topix-pharmaceuticals/2458505/Topix Pharmaceuticals, Inc. has partnered with New Mountain Capital, LLC, a growth-oriented investment firm that currently manages over $15 billion in assets. New Mountain, a New York-based private equity firm, identified Topix through a proactive focus in the life sciences and aestheti
- FDA Greenlights First-Ever OTC Retinoidhttps://practicaldermatology.com/news/fda-greenlights-first-ever-otc-retinoid/2458507/The U.S. Food and Drug Administration (FDA) approved Differin Gel 0.1% (adapalene), a once-daily topical gel for the over-the-counter (OTC) treatment of acne in people 12 years of age and older. Differin Gel 0.1% is the first retinoid to be made available OTC for the
- Valeant Terminates European Licensing Rights for Brodalumabhttps://practicaldermatology.com/news/valeant-terminates-european-licensing-rights-for-brodalumab/2458512/Valeant Pharmaceuticals International, Inc.'s affiliate and AstraZeneca have amended Valeant's license for brodalumab, an IL-17 receptor monoclonal antibody under regulatory review for patients with moderate-to-severe plaque psoriasis, to terminate Valeant's right to develop and comme
- Daily ‘Soak and Smear' OKed for Kids with Eczemahttps://practicaldermatology.com/news/daily-soak-and-smear-oked-for-kids-with-eczema/2458513/Daily bathing is fine for children with eczema as long as it's followed by lots of moisturizer, according to a new article in Annals of Allergy, Asthma and Immunology. Researchers led by Portl
- Global Psoriasis Survey: 85% of US Respondents Faced Social Stigma Because of Psoriasishttps://practicaldermatology.com/news/global-psoriasis-survey-85-of-us-respondents-faced-social-stigma-because-of-psoriasis/2458514/Novartis released new results from its Clear About Psoriasis Survey, the largest global survey to date of people with moderate-to-severe psoriasis. Findings reveal 85 percent of US respondents have suffered from social stigma like discrimination and humiliation because of their disease. In additi
- Novel Impetigo Drug on the Horizonhttps://practicaldermatology.com/news/new-impetigo-drug-on-the-horizon/2458518/Medimetriks Pharmaceuticals, Inc. submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ozenoxacin cream, 1%, a novel, non-fluorinated quinolone for the treatment of impetigo. Medimetriks licensed e
- Virtual Peer Pressure on Social Media May Up Indoor Tanning in Young Womenhttps://practicaldermatology.com/news/virtual-peer-pressure-on-social-media-may-up-indoor-tanning-in-young-women/2458523/Use of Twitter and Instagram may be driving an uptick in indoor tanning among young adult women, a new study suggests. The study, which appears in the July issue of the Journal of the American Academ
- New Hair Restoration Group Started for Dermatologists, Facial Plastic Surgeons and Plastic Surgeonshttps://practicaldermatology.com/news/new-hair-restoration-group-started-for-dermatologists-facial-plastic-surgeons-and-plastic-surgeons/2458525/Introducing The North American Society for Hair Restoration (NASHR), a new non-profit medical association comprising plastic surgeons, facial plastic surgeons and dermatologists who have the proper training for hair transplantation surgery.
- Free Sunscreen Program Expands in Massachusetts Thanks to $25,000 Gifthttps://practicaldermatology.com/news/free-sunscreen-program-expands-in-mass-thanks-to-25000-gift/2458526/The Melanoma Foundation of New England (MFNE) received a $25,000 gift from the Arbella Insurance Foundation to allow its Practice Safe Skin program
- Restylane Turns 20, Galderma Launches New Syringehttps://practicaldermatology.com/news/restylane-turns-20-galderma-launches-new-syringe/2458533/Happy 20th Restylane®! Galderma is celebrating the 20th anniversary of the Restylane line of products. The line includes Restylane®, Restylane-L®, Restylane® Lyft with Lidocaine and Restylane® Si